AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2010
Jan 25, 2010
35274_dirs_2010-01-25_ef232882-2353-471b-a262-438858ee311f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2009-12-31
Reporting Person: OLDAKER WILLIAM CLYDE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-07-28 | Common Stock | P | 4131 | $1.38 | Acquired | 72531 | Direct |
| 2008-07-28 | Common Stock | P | 1600 | $1.37 | Acquired | 74131 | Direct |
| 2008-07-28 | Common Stock | P | 2400 | $1.40 | Acquired | 76531 | Direct |
| 2008-07-28 | Common Stock | P | 2400 | $1.41 | Acquired | 78931 | Direct |
| 2008-07-28 | Common Stock | P | 369 | $1.42 | Acquired | 79300 | Direct |
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Capital/Financing Update
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11